MGAT3 and neoplasm: It is worth noting that future research needs to systematically explore whether and how MGAT3-mediated bisecting GlcNAc alterations affect other crucial immune cell subsets in the TME, such as myeloid-derived suppressor cells, tumor-associated macrophages, regulatory T cells, and natural killer cells [59].